Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Re: POET like a fase 3 biopharma waiting for results.
I can only assume that the share price hasn't moved, largely as a result of the exchange we sit on. Companies on it are not trusted and remain in relative anonymity. I am confident that once we get to the Nasdaq this will change. There must be a queue of large investors waiting to get involved. No doubt this is one of the reasons management bought the rs into play.

The news will arrive in due course and I think the market will react accordingly. The SP isn't a major concern right now. But of course this will change once we get news and hope to move to the Nasdaq.
Share
New Message
Please login to post a reply